These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25457058)

  • 21. Optical coherence tomography and intravascular ultrasound of double kissing crush coronary bifurcation stenting.
    McGeoch RJ; Tanaka K; Kotowycz MA; Bezerra HG; Džavík V
    EuroIntervention; 2014 Jul; 10(3):338. PubMed ID: 24862341
    [No Abstract]   [Full Text] [Related]  

  • 22. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.
    Gori T; Schulz E; Hink U; Kress M; Weiers N; Weissner M; Jabs A; Wenzel P; Capodanno D; Münzel T
    JACC Cardiovasc Interv; 2015 May; 8(6):770-777. PubMed ID: 25999097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very late stent thrombosis 5 years after implantation of a sirolimus-eluting stent observed by angioscopy and optical coherence tomography.
    Ishihara T; Awata M; Fujita M; Watanabe T; Iida O; Ishida Y; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2013 May; 6(5):e28-30. PubMed ID: 23702022
    [No Abstract]   [Full Text] [Related]  

  • 25. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very Late Scaffold Thrombosis Due to Insufficient Strut Apposition.
    Meincke F; Spangenberg T; Heeger CH; Bergmann MW; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1768-9. PubMed ID: 26476613
    [No Abstract]   [Full Text] [Related]  

  • 27. Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study.
    Tenekecioglu E; Torii R; Bourantas C; Sotomi Y; Cavalcante R; Zeng Y; Collet C; Crake T; Suwannasom P; Onuma Y; Serruys PW
    EuroIntervention; 2017 Dec; 13(11):1327-1335. PubMed ID: 28590249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study.
    Shiratori Y; Brugaletta S; Alvarez-Contreras L; Azpeitia Y; Ospino N; Gaido S; Delahanty A; Santos A; Martin-Yuste V; Masotti M; Serruys PW; Windecker S; Sabaté M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E428-36. PubMed ID: 23441068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Biomechanical Behavior and Healing Profile of a Novel Thinned Wall Ultrahigh Molecular Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.
    Cheng Y; Gasior P; Xia JG; Ramzipoor K; Lee C; Estrada EA; Dokko D; McGregor JC; Conditt GB; McAndrew T; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.
    Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R
    JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis.
    Ielasi A; Cortese B; Steffenino G
    JACC Cardiovasc Interv; 2015 Aug; 8(10):e171-e172. PubMed ID: 26315753
    [No Abstract]   [Full Text] [Related]  

  • 32. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.
    Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK
    Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A very late thrombosis in a bioresorbable vascular scaffold.
    Giacchi M; Pedrazzini G; Moccetti T; Moccetti M
    EuroIntervention; 2015 Nov; 11(7):e1. PubMed ID: 26603865
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 36. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
    Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S;
    JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple interstrut cavities: a potential mechanism for very late stent thrombosis? Insights from optical coherence tomography.
    Jama A; Prasad A
    JACC Cardiovasc Interv; 2012 Sep; 5(9):995-6. PubMed ID: 22995888
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of Bioresorbable Vascular Scaffold in Acute Dissection: Insights From Optical Coherence Tomography.
    Basavarajaiah S; Naganuma T; Qadir M
    JACC Cardiovasc Interv; 2016 Jan; 9(1):e5-e9. PubMed ID: 26762926
    [No Abstract]   [Full Text] [Related]  

  • 39. "Full Plastic-Jacket": Reconstruction of 18 cm of coronary arteries with bioresorbable vascular scaffolds in a young patient with ST-elevation myocardial infarction and multivessel disease.
    Denegri A; Frangieh AH; D'Ascenzo F; Ghadri JR; Nietlispach F; Templin C
    Cardiol J; 2017; 24(2):221-223. PubMed ID: 28421591
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.
    Cheng Y; Gasior P; Shibuya M; Ramzipoor K; Lee C; Estrada EA; Dokko D; McGregor JC; Conditt GB; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27694138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.